BioSpace News Archive

BioForest

Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses

LHF-535, Kineta’s lead biodefense asset, is a novel once-daily oral antiviral drug currently being evaluated in Phase 1 safety trials in healthy volunteers.

July 15, 2019
·
3 min read
BioForest

The EndBrainCancer Initiative Calls on All Americans to Recognize and Support the Inaugural National Glioblastoma Awareness Day on July 17th

In June, the U.S. Senate took swift action and passed Senate Resolution 245 by unanimous consent. July 17, 2019 is officially “Glioblastoma Awareness Day” nationally (#GBMDay)! Glioblastoma (GBM) is the most common and deadly form of brain cancer.

July 15, 2019
·
2 min read
Business

CipherHealth and Medline Partner to Advance Technology’s Role in Home Health Care

Medline to expand CipherOutreach’s reach in market to help more patients benefit automated patient communication

July 15, 2019
·
3 min read
Business

PharmaCyte Biotech Appoints Cellular Expert to Medical and Scientific Advisory Board

Mr. Judd has worked for many years with the cells that PharmaCyte uses in its treatment of cancer and has a wealth of knowledge regarding their growth properties

July 15, 2019
·
5 min read
Genetown

Call for Presentations Open for Healthcare Robotics Engineering Forum

WTWH Media today announced that the Call for Presentations for the Healthcare Robotics Engineering Forum is now open. The Healthcare Robotics Engineering Forum takes place December 9-10, 2019 at the Santa Clara Convention Center.

July 15, 2019
·
2 min read
Deals

Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California

Phase 1 clinical trial anticipated to commence in 2020

July 15, 2019
·
7 min read
FDA

FDA approves Bayer’s Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Coronary artery disease (CAD) is an important public health issue-- a disease that affects 16.5 million Americans

July 15, 2019
·
9 min read
Pharm Country

Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing

Sun Pharmaceutical Industries Ltd. announced the U.S. launch of Ezallor Sprinkle™ capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30-35% of long-term care residents.

July 15, 2019
·
12 min read
Deals

Marken Acquires Three European Logistics Companies

Marken announced that they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier.

July 15, 2019
·
2 min read
Business

Poxel Reports Financial Update for Cash and Revenue for the Second Quarter and the First Half 2019 and Provides Corporate Update

POXEL SA announced its cash position and revenue for the second quarter and the first half of 2019.

July 15, 2019
·
10 min read